Search results
Results from the WOW.Com Content Network
Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court.
Robert Charles Gallo (/ ˈ ɡ ɑː l oʊ /; born March 23, 1937) is an American biomedical researcher.He is best known for his role in establishing the human immunodeficiency virus (HIV) as the infectious agent responsible for acquired immune deficiency syndrome (AIDS) and in the development of the HIV blood test, and he has been a major contributor to subsequent HIV research.
Gilead (GILD) has filed a lawsuit against the Federal Government alleging violation of four Material Transfer Agreements (MTAs) and a Clinical Trial Agreement (CTA) by the US Centers for Disease ...
However, Gilead has faced its own set of inquiries and legal settlements related to patent gaming — most recently a $40 million settlement for slowing the release of a life-saving HIV treatment ...
[2] [3] He joined Gilead Sciences in 1990 as vice president for research and development. [4] [1] Gilead is known for developing drugs such as Atripla (for HIV/AIDS) and commercializing Sovaldi for the treatment of the liver virus hepatitis C. Martin is the recipient of a number of awards, including the Biotechnology Heritage Award (2017).
HIV was first identified as the cause of AIDS and isolated in parallel by researchers Luc Montagnier in France and Robert Gallo in the United States in 1983 and 1984. [3] Without treatment, HIV is inevitably fatal, with a median survival time of 8–10 years. [ 4 ]
(Reuters) - Gilead Sciences said on Wednesday it has granted royalty-free licenses to six generic drug manufacturers to make and sell cheaper copycat versions of its HIV prevention medicine in 120 ...
This is a timeline of HIV/AIDS, including but not limited to cases before 1980. Pre-1980s See also: Timeline of early HIV/AIDS cases Researchers estimate that some time in the early 20th century, a form of Simian immunodeficiency virus found in chimpanzees (SIVcpz) first entered humans in Central Africa and began circulating in Léopoldville (modern-day Kinshasa) by the 1920s. This gave rise ...